Two Surveys Raise Questions about Willingness of Consumers to Pay Pathology Laboratories for Expensive Genetic Cancer Tests

Oct 10, 2012 | Coding, Billing, and Collections, Laboratory News, Laboratory Pathology

This finding is reinforced by the fact that high-deductible health plans are now the second most popular plan option offered by the nation’s employers Getting paid for expensive genetic cancer tests is likely to be tougher for clinical laboratories when the patient is covered by a high-deductible health plan. There are two trends that are contributing to this situation, each highlighted by recently-published studies. One trend is the rapid growth of consumer-driven health plans (CDHPs). The...
;